Methionine oxidized apolipoprotein A-I at the crossroads of HDL biogenesis and amyloid formation. 2018

Andrzej Witkowski, and Gary K L Chan, and Jennifer C Boatz, and Nancy J Li, and Ayuka P Inoue, and Jaclyn C Wong, and Patrick C A van der Wel, and Giorgio Cavigiolio
Children's Hospital Oakland Research Institute (CHORI), Oakland, California, USA.

Apolipoprotein A-I (apoA-I) shares with other exchangeable apolipoproteins a high level of structural plasticity. In the lipid-free state, the apolipoprotein amphipathic α-helices interact intra- and intermolecularly, providing structural stabilization by self-association. We have reported that lipid-free apoA-I becomes amyloidogenic upon physiologically relevant (myeloperoxidase-mediated) Met oxidation. In this study, we established that Met oxidation promotes amyloidogenesis by reducing the stability of apoA-I monomers and irreversibly disrupting self-association. The oxidized apoA-I monomers also exhibited increased cellular cholesterol release capacity and stronger association with macrophages, compared to nonoxidized apoA-I. Of physiologic relevance, preformed oxidized apoA-I amyloid fibrils induced amyloid formation in nonoxidized apoA-I. This process was enhanced when self-association of nonoxidized apoA-I was disrupted by thermal treatment. Solid state NMR analysis revealed that aggregates formed by seeded nonoxidized apoA-I were structurally similar to those formed by the oxidized protein, featuring a β-structure-rich amyloid fold alongside α-helices retained from the native state. In atherosclerotic lesions, the conditions that promote apoA-I amyloid formation are readily available: myeloperoxidase, active oxygen species, low pH, and high concentration of lipid-free apoA-I. Our results suggest that even partial Met oxidation of apoA-I can nucleate amyloidogenesis, thus sequestering and inactivating otherwise antiatherogenic and HDL-forming apoA-I.-Witkowski, A., Chan, G. K. L., Boatz, J. C., Li, N. J., Inoue, A. P., Wong, J. C., van der Wel, P. C. A., Cavigiolio, G. Methionine oxidized apolipoprotein A-I at the crossroads of HDL biogenesis and amyloid formation.

UI MeSH Term Description Entries
D008075 Lipoproteins, HDL A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. HDL lipoproteins, synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. HDL also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. HDL plasma level has been inversely correlated with the risk of cardiovascular diseases. High Density Lipoprotein,High-Density Lipoprotein,High-Density Lipoproteins,alpha-Lipoprotein,alpha-Lipoproteins,Heavy Lipoproteins,alpha-1 Lipoprotein,Density Lipoprotein, High,HDL Lipoproteins,High Density Lipoproteins,Lipoprotein, High Density,Lipoprotein, High-Density,Lipoproteins, Heavy,Lipoproteins, High-Density,alpha Lipoprotein,alpha Lipoproteins
D008715 Methionine A sulfur-containing essential L-amino acid that is important in many body functions. L-Methionine,Liquimeth,Methionine, L-Isomer,Pedameth,L-Isomer Methionine,Methionine, L Isomer
D009195 Peroxidase A hemeprotein from leukocytes. Deficiency of this enzyme leads to a hereditary disorder coupled with disseminated moniliasis. It catalyzes the conversion of a donor and peroxide to an oxidized donor and water. EC 1.11.1.7. Myeloperoxidase,Hemi-Myeloperoxidase,Hemi Myeloperoxidase
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000682 Amyloid A fibrous protein complex that consists of proteins folded into a specific cross beta-pleated sheet structure. This fibrillar structure has been found as an alternative folding pattern for a variety of functional proteins. Deposits of amyloid in the form of AMYLOID PLAQUES are associated with a variety of degenerative diseases. The amyloid structure has also been found in a number of functional proteins that are unrelated to disease. Amyloid Fibril,Amyloid Fibrils,Amyloid Substance,Fibril, Amyloid,Fibrils, Amyloid,Substance, Amyloid
D016632 Apolipoprotein A-I The most abundant protein component of HIGH DENSITY LIPOPROTEINS or HDL. This protein serves as an acceptor for CHOLESTEROL released from cells thus promoting efflux of cholesterol to HDL then to the LIVER for excretion from the body (reverse cholesterol transport). It also acts as a cofactor for LECITHIN CHOLESTEROL ACYLTRANSFERASE that forms CHOLESTEROL ESTERS on the HDL particles. Mutations of this gene APOA1 cause HDL deficiency, such as in FAMILIAL ALPHA LIPOPROTEIN DEFICIENCY DISEASE and in some patients with TANGIER DISEASE. Apo A-I,Apo A-1,Apo A-I Isoproteins,Apo A1,Apo AI,ApoA-1,ApoA-I,Apolipoprotein A-1,Apolipoprotein A-I Isoprotein-2,Apolipoprotein A-I Isoprotein-4,Apolipoprotein A-I Isoproteins,Apolipoprotein A1,Apolipoprotein AI,Apolipoprotein AI Propeptide,Pro-Apo A-I,Pro-Apolipoprotein A-I,Proapolipoprotein AI,Apo A I Isoproteins,Apolipoprotein A 1,Apolipoprotein A I,Apolipoprotein A I Isoprotein 2,Apolipoprotein A I Isoprotein 4,Apolipoprotein A I Isoproteins,Pro Apo A I,Pro Apolipoprotein A I
D050197 Atherosclerosis A thickening and loss of elasticity of the walls of ARTERIES that occurs with formation of ATHEROSCLEROTIC PLAQUES within the ARTERIAL INTIMA. Atherogenesis,Atherogeneses,Atheroscleroses
D019906 Nuclear Magnetic Resonance, Biomolecular NMR spectroscopy on small- to medium-size biological macromolecules. This is often used for structural investigation of proteins and nucleic acids, and often involves more than one isotope. Biomolecular Nuclear Magnetic Resonance,Heteronuclear Nuclear Magnetic Resonance,NMR Spectroscopy, Protein,NMR, Biomolecular,NMR, Heteronuclear,NMR, Multinuclear,Nuclear Magnetic Resonance, Heteronuclear,Protein NMR Spectroscopy,Biomolecular NMR,Heteronuclear NMR,Multinuclear NMR,NMR Spectroscopies, Protein,Protein NMR Spectroscopies,Spectroscopies, Protein NMR,Spectroscopy, Protein NMR

Related Publications

Andrzej Witkowski, and Gary K L Chan, and Jennifer C Boatz, and Nancy J Li, and Ayuka P Inoue, and Jaclyn C Wong, and Patrick C A van der Wel, and Giorgio Cavigiolio
February 2018, FEBS open bio,
Andrzej Witkowski, and Gary K L Chan, and Jennifer C Boatz, and Nancy J Li, and Ayuka P Inoue, and Jaclyn C Wong, and Patrick C A van der Wel, and Giorgio Cavigiolio
February 2010, Proceedings of the National Academy of Sciences of the United States of America,
Andrzej Witkowski, and Gary K L Chan, and Jennifer C Boatz, and Nancy J Li, and Ayuka P Inoue, and Jaclyn C Wong, and Patrick C A van der Wel, and Giorgio Cavigiolio
March 2009, Journal of lipid research,
Andrzej Witkowski, and Gary K L Chan, and Jennifer C Boatz, and Nancy J Li, and Ayuka P Inoue, and Jaclyn C Wong, and Patrick C A van der Wel, and Giorgio Cavigiolio
March 2017, Biochemistry,
Andrzej Witkowski, and Gary K L Chan, and Jennifer C Boatz, and Nancy J Li, and Ayuka P Inoue, and Jaclyn C Wong, and Patrick C A van der Wel, and Giorgio Cavigiolio
August 1996, Journal of lipid research,
Andrzej Witkowski, and Gary K L Chan, and Jennifer C Boatz, and Nancy J Li, and Ayuka P Inoue, and Jaclyn C Wong, and Patrick C A van der Wel, and Giorgio Cavigiolio
January 2000, International journal of pharmaceutics,
Andrzej Witkowski, and Gary K L Chan, and Jennifer C Boatz, and Nancy J Li, and Ayuka P Inoue, and Jaclyn C Wong, and Patrick C A van der Wel, and Giorgio Cavigiolio
March 2020, Journal of lipid research,
Andrzej Witkowski, and Gary K L Chan, and Jennifer C Boatz, and Nancy J Li, and Ayuka P Inoue, and Jaclyn C Wong, and Patrick C A van der Wel, and Giorgio Cavigiolio
November 2007, Journal of lipid research,
Andrzej Witkowski, and Gary K L Chan, and Jennifer C Boatz, and Nancy J Li, and Ayuka P Inoue, and Jaclyn C Wong, and Patrick C A van der Wel, and Giorgio Cavigiolio
November 2023, The Journal of biological chemistry,
Andrzej Witkowski, and Gary K L Chan, and Jennifer C Boatz, and Nancy J Li, and Ayuka P Inoue, and Jaclyn C Wong, and Patrick C A van der Wel, and Giorgio Cavigiolio
July 2015, Archives of medical research,
Copied contents to your clipboard!